OrganiGram Holdings Inc.
TSX VENTURE : OGI
OTCQB : OGRMF

OrganiGram Holdings Inc.

September 02, 2016 16:30 ET

OrganiGram Announces Issuance of Stock Options

MONCTON, NEW BRUNSWICK--(Marketwired - Sept. 2, 2016) - OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) ("OrganiGram" or the "Company") announces that it has issued an aggregate of 835,600 incentive stock options to various directors and officers of the Company at an exercise price of $1.42 per share. In accordance with the Company's Stock Option Plan, the foregoing options shall vest over three-year periods and shall expire 10 years after issuance.

All of the above-mentioned options have been granted pursuant to the Company's Stock Option Plan which has been previously approved by the Company's shareholders and the TSX Venture Exchange.

About OrganiGram Holdings Inc.

OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram's facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations ("ACMPR").

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • OrganiGram Holdings Inc.
    Giselle Doiron
    Director of Investor and Media Relations
    (506) 801-8986
    www.organigram.ca